Sanofi waved goodbye to its long running Zantac troubles in Q4 as its US Consumer Healthcare operation got back on track.
Speaking at the French pharma giant reported its Q4 and full year results, Sanofi Consumer Healthcare head Julie Van Ongevalle said the firm had been
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?